The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: 123I-MIBG Scintigraphy in Patients Being Evaluated for Neuroendocrine Tumors
Official Title:
Study ID: NCT01373736
Brief Summary: The study is designed to study the safety and effectiveness of 123I-MIBG as a diagnostic imaging agent in evaluating patients with known or suspected neuroendocrine tumors.
Detailed Description:
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Vancouver Coastal Health, Vancouver, British Columbia, Canada
Name: Daniel Worsley, MD
Affiliation: Vancouver Coastal Health
Role: PRINCIPAL_INVESTIGATOR